Kallyope initiates study assessing new oral nutrient receptor agonists for the treatment of obesity
Kallyope has initiated a Phase 2 trial evaluating K-757 and K-833, new oral nutrient receptor agonists being studied for obesity and Type...
top of page
Browse by category
Search
Browse by tag
bottom of page